A

AMLo Biosciences

17 employees

AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Skin Cancer
Melanoma
Biomarkers

Date founded

2017

Funding rounds raised

Total raised

$3.3M

from 3 investors over 3 rounds

A

AMLo Biosciences raised $3.3M on April 21, 2022

Investors: Ascension Life Fund and Future Planet Capital

A

AMLo Biosciences raised undisclosed on November 1, 2020

Investors: Future Planet Capital

FAQ